7.29.2007

Cinnamon and blood sugar

Swedish researchers published a small but interesting trial of Cinnamon (Cinnamonum verum) in the American Journal of Clinical Nutrition. Fourteen non-diabetics were in the group, and half received cinnamon powder at a dose of 6 grams in their rice pudding (clearly, not a blinded trial and much less tasty for the control group).
Then, starting 15 minutes after the pudding and continuing for an hour and a half, they measured both the rate of gastric emptying and the blood sugar rise. Cinnamon slowed both down, but the effect was much greater for the blood sugar itself.
It seems to me that we are watching the synergy of crude plant preparations here: the gut is slowing down, relaxing due to the carminative volatile oils in the ground cinnamon bark. At the same time, mucilage present in the powder is binding the sugars from the meal, slowing their release into the bloodstream. Finally, there are biochemical reasons, at the level of the cell surface and the cytoplasm, why Cinnamon seems to control postprandial blood sugar very well (see additional recent studies below), but this basic idea works well for any volatile / mucilage (carminative / demulcent) combination. I hope we stay away from the idea of refining and patenting a constituent from cinnamon to treat diabetes.
The other interesting point from a clinical perspective is that this trial uses a nice (6g) dose of cinnamon for a single meal. As the studies below show, lower doses (1g to 2g per day) don't seem to do very much. This makes sense, as you need some bulk of mucilage and 1 gram of powder is a very small amount; additionally, a dose of 6g to 12g a day is much more in line with traditional usage.


Related research, via PubMed:




Altschuler JA, Casella SJ, MacKenzie TA, Curtis KM.


Free Full TextThe effect of cinnamon on A1C among adolescents with type 1 diabetes.
Diabetes Care. 2007 Apr;30(4):813-6.
PMID: 17392542 [PubMed - indexed for MEDLINE]


Pham AQ, Kourlas H, Pham DQ.


AbstractCinnamon supplementation in patients with type 2 diabetes mellitus.
Pharmacotherapy. 2007 Apr;27(4):595-9.
PMID: 17381386 [PubMed - in process]


Cao H, Polansky MM, Anderson RA.


AbstractCinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes.
Arch Biochem Biophys. 2007 Mar 15;459(2):214-22. Epub 2007 Jan 25.
PMID: 17316549 [PubMed - indexed for MEDLINE]



Subash Babu P, Prabuseenivasan S, Ignacimuthu S.


AbstractCinnamaldehyde--a potential antidiabetic agent.
Phytomedicine. 2007 Jan;14(1):15-22. Epub 2006 Nov 30.
PMID: 17140783 [PubMed - indexed for MEDLINE]


Mang B, Wolters M, Schmitt B, Kelb K, Lichtinghagen R, Stichtenoth DO, Hahn A.





AbstractEffects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2.
Eur J Clin Invest. 2006 May;36(5):340-4.
PMID: 16634838 [PubMed - indexed for MEDLINE]


Vanschoonbeek K, Thomassen BJ, Senden JM, Wodzig WK, van Loon LJ.


Free Full TextCinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients.
J Nutr. 2006 Apr;136(4):977-80.
PMID: 16549460 [PubMed - indexed for MEDLINE]


Kim SH, Hyun SH, Choung SY.


AbstractAnti-diabetic effect of cinnamon extract on blood glucose in db/db mice.
J Ethnopharmacol. 2006 Mar 8;104(1-2):119-23. Epub 2005 Oct 5.
PMID: 16213119 [PubMed - indexed for MEDLINE]



Verspohl EJ, Bauer K, Neddermann E.


AbstractAntidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro.
Phytother Res. 2005 Mar;19(3):203-6.
PMID: 15934022 [PubMed - indexed for MEDLINE]

Cannabis and psychosis

The current issue of the Lancet published a meta-analysis of multiple trials concerning the use of cannabis and its association with mental illness. There were 35 longitudinal studies selected for the analysis. All of them followed patients starting before any mental illness, and included cannabis use as a variable along with many other factors, such as personality, background, use of other drugs. 7 out of 35 trials concerned "psychosis" (ranging from 'mild symptoms' to 'schizophrenia') and were the only ones that showed any connection with cannabis use. Conditions of mental illness such as depression, mood disturbances, or others did not have any connection.
The study's authors rightly point out that there can be no way to say for certain that there is a direct causal link between smoking pot and experiencing at least one major psychotic episode (and the definitions are a bit of a problem for me here as well), but that caution, especially in folks with a personal or family history, is warranted. In the end, I would have to agree -- but this is true of any medicine, really...
There is a brief (6-minute) interview with the study's author here.

7.19.2007

Docs and nurses use "alternative medicine"

An interesting report details the uses of herbs and dietary supplements by doctors, nurses, and other mainstream health care providers. Although it focuses on clinicians enrolled in an online course about alternative medicine and supplements, the study still gives some interesting tidbits: first off, over 80% of the practitioners used some form of herb or supplement. The top choices are things like multivitamins and specific vits; but herbs such as green tea, chamomile, flax, cinnamon and Echinacea are right up there. I keep saying that things are changing with the new batches of allopaths coming out of the medical and nursing schools: I hope the positive attitudes can translate to good education, both of the care providers and their patients!

Salacia oblonga for type 2 diabetes

A tropical shrub used in Ayurveda for controlling obesity and its associated health complications, Salacia oblonga (a.k.a. Saptrangi) has shown promise in some limited trials that looked at its ability to reduce high blood sugar in diabetes. A new trial goes into more detail: the extract of the root and stems of this plant lowered post-meal blood glucose by about 25%, while also reducing the amount of circulating insulin in the blood. Thus, it seems to sensitize the physiology to insulin, which reverses the trend of insulin resistance seen in type 2 diabetes. A 25% reduction is significant: it could bring a diabetic patient with postprandial blood glucose levels over 150 down to the "normal" range of 120.

7.18.2007

Curcumin and Alzheimer's

Though these findings come from a test tube, the results are nonetheless pretty interesting: a study carried out at UCLA reveals that immune cells are much more active against the amyloid plaques thought to contribute to Alzheimer's disease when treated with curcumin, one of the many compounds in turmeric.
This delicious rhizome in the ginger family has been conclusively shown to have anti-inflammatory power, and now this in-vitro research seems to hint at power beyond simple reduction of inflammation.
Amyloid plaques, which are tangles of protein thought to interfere with neuronal function in Alzheimer's disease, have a close link to inflammatory processes. Perhaps ongoing ingestion of turmeric in the diet can have a protective effect if initiated early on in life. I'd be interested in epidemiological reviews of the incidence of Alzheimer's in cultures who use a lot of curry (rich in turmeric) versus those who use none...

7.14.2007

Solarfest 2007 - green buildings!

This summer festival highlights sustainable energy and building technologies. I've been asked to talk about the laboratory and apothecary here at Grian Herbs, and share a slideshow that documents the construction of this straw-bale passive-solar building we've been using to host classes, do tincture production, and grow tropical botanicals year-round. Here are a few pictures:

















The hemlock timber frame
















The bale walls going up
















A first coat of clay plaster...
















Done!















Vitex and Gotu Kola in the greenhouse.
















Inside, the classroom and processing spaces.













And a peek inside the apothecary...

7.13.2007

Red Reishi - safety update

Ganoderma lucidum, the Red Reishi shelf mushroom, and its closely allied species Ganoderma tsugae (native to the Northeast U.S.), are some of my favorites for rebalancing immune function and harmonizing liver metabolism. Excellent for allergies, autoimmune conditions, and cancer, this mushroom has always enjoyed a traditional reputation for safety. Now, a small in-vivo trial published in the American Journal of Chinese Medicine confirms its general safety by looking at markers of immunity and inflammation in healthy subjects receiving 2 grams of Reishi extract twice a day for ten days. Perfectly safe, are the conclusions.
I use a double-extraction process for most medicinal mushrooms, in order to obtain both the alcohol-soluble phenolic compounds and the more traditional water-soluble polysaccharides. With the addition of a little gylcerin in the menstruum, the extract stays well-emulsified and isn't quite so bitter.

7.10.2007

Chocolate in hypertension

A new, in-vivo German trial shows that even modest amounts of dark chocolate, consumed daily two hours after dinner, has positive effects on reducing high blood pressure. In comparing the consumption of dark vs. white chocolate (the latter not being chocolate at all), blood pressure was effectively lowered in the treatment arm of 44 adults aged 56-73.
I've written about chocolate before, and this new research just confirms that even tiny doses of cocoa flavonoids (under 30 calories /day!) benefit the circulatory system in many ways. Of course, I would recommend a bit more -- but as the study's authors comment, don't blow your calorie budget!

7.08.2007

Jumping to conclusions

For your enjoyment, the conclusions of a pilot study on warfarin / herb interactions:

The present survey highlights the potential risk of confidence with the 'natural world', the lack of discussion on this argument among health care providers and patients on warfarin therapy and the need to monitor strictly the INR value.
To this I would add (especially in the wake of recent experience): increased levels of physician education on the effects of the 'natural world' might help increase their confidence (heresy, I know). Many botanicals are perfectly safe to use in conjunction with anticoagulant therapy; others are not. A clear understanding of the underlying pharmacology and physiology is the best place to start.

I just couldn't get over how the first conclusion of this study, which rightly identifies poor communication between docs and patients and highlights the dangers that result, was to lay the blame at the feet of the 'natural world'. Fortunately, I think this kind of attitude is waning (eternal optimist).

Some plants from Cape Breton















Our camping excursion to the Highlands National Park on Cape Breton island offered a wide diversity of environments to explore. Lots of terrain had poor, thin soils and supported acidic "barrens", covered in heaths and moss.
The few black spruces are probably over 100 years old, and though barely 10 feet tall are covered in Usnea.




















Heath groundcover






















Reindeer moss

















In places where the barrens got more soggy, fens developed and more specialized plants thrived, like this Sundew (Drosera intermedia, the spoonleaf sundew).
















Pitcher plant (Sarracenia purpurea)





Dragon's mouth (Arethusa) orchid





Labrador tea (Ledum palustre)




Bogbean (Menyanthes trifoliata) a.k.a. Buckbean




Local Larch (Larix)










Out by the coast, we find familiar friends.




Yarrow (Achillea millefolium)




Red Clover (Trifolium pratense)




A Campanula (C. rotundifolia, perhaps)



And, a bit further into the woods, a white bog orchid (Habenaria dilatata)

6.26.2007

Echinacea effective (we knew that)

A meta-analysis of multiple trials covering over 1,500 people and published in the Lancet not only revealed that Echinacea helps avert and shorten colds and flus, but also got substantial press coverage in the mainstream media. Nothing new for herbalists - merely a vindication of what we have known for a while: when taken at adequate doses in the real world, Echinacea species really are effective. Beyond colds and flus, I often use this plant for topical bacterial (e.g. Staph) infections, to excellent effect -- and considering drug-resistant staph may be much more widespread than we thought, Echinacea will become much more important than it already is.
As far as the new meta-analysis goes, HerbalGram wrote a review, and USA Today gave mass media's take.

6.25.2007

New FDA rules for herbal preparations, practitioners

The final rule on good manufacturing practices for herbal / nutritional supplements just got handed down this weekend. While it leaves some leeway for self-regulation, it does mandate some very difficult requirements, especially for practitioners who are essentially "manufacturing" a product each time they blend a tincture. These rules have been a long time coming, and will be phased in for small companies by 2011...
We need to dissect the full document and consider it with the advancing Traditional Medicines Congress (and its opposition) in an attempt to understand the very real changes herbalism will face in the coming years. Let's stay informed and keep our voices heard.

High-dose Ginkgo extract helps control anxiety

The standardized extract of Ginkgo biloba, used for managing cardiovascular disease, improving blood oxygenation, reducing inflammation in colitis, and slowing the decline of brain function as we get older, seems now to reduce anxiety in people of all ages.
A new study (107 subjects) showed very significant improvement in the symptoms associated with "generalized anxiety disorder". The product used was EGb 761, the usual extract standardized to 24% ginkgo-flavone glycosides and 6% terpenoids. The dose was higher than what I often suggest, and the authors noticed a dose-dependent reduction in symptoms (they were giving 480mg and 240mg of extract daily).

Perhaps a bad idea?

Trying to stimulate the immune system into producing antibodies to the active form of angiotensin, an enzyme involved in the complex balance of chemicals that regulate blood pressure, might not be the safest point of intervention for this disease. Considering the prevalence of autoimmune conditions, I would be concerned about the possibility of long-term effects. Nevertheless, according to the New Scientist, Cytos Biotechnology in Zurich seems to be trying out such a "vaccine".

Perhaps we should start training the immune system to attack a variety of other targets as well! Neurotransmitters for "mood disorders"? Hormones? I'm sure the resulting inflammation would be negligible.

6.19.2007

Soy isoflavone helps bone density

Research from the University of Messina in Italy points to genistein, and isoflavone from soy (Glycine max), as a possible treatment for poor bone density and osteopenia in post-menopausal women. While the scientists didn't track fractures or other negative outcomes of poor bone density, they did document an increase in BMD in the treatment arm of the study (the whole study included 389 women). The general conclusions indicate that soy contains phytoestrogenic isoflavones that reverse the trend of bone loss that occurs in post-menopausal women.
The researchers caution that, genistein being a phytoestrogen, the use of soy is dangerous for those with a history of endometrial or breast cancer (considered to often be estrogen-dependent). In response, I offer two considerations: first, no research has even indicated conclusively that phytoestrogens stimulate cancer in vivo, and additional research points to the possible cancer-preventive role of these chemicals. Second, ethnic and geographic groups that traditionally use an abundance of soy in their diet generally show lower rates of breast cancer.
As with many plant chemicals taken in their unadulterated states (and especially as crude, whole preparations), I suspect soy isoflavones play an amphoteric role in the human physiology, increasing what is deficient and reducing the effects of that which is excessive -- in this case, helping to modulate the effects of estradiol.

6.18.2007

Plants recognize their siblings

We already know that the rhizosphere, the zone of soil around the roots of plants, is teeming with chemical signals from the plants themselves as well as from symbiotic bacteria, fungi, and other life. This chemical crosstalk is akin to the air-based communication accomplished through pheromones (in humans, other mammals, insects, etc...), and undoubtedly provides a rich, stimulating and ongoing dialogue for the plants.
In many cases, chemicals secreted from plant roots contribute to survival: witness allelopathy, the ability of some plants such as wormwood, goldenrod, or many cover crops to inhibit the growth of other species in their rhizospheres. It has always fascinated me that the plants can recognize members of their own species and selectively inhibit the growth of everything else -- but after all, they are different species, and a genetic resistance to a poison is not difficult to imagine.
Now, in a beautiful study published in Biology Letters, we learn that members of the same species alter their competitive behavior based on whether or not they are growing next to their siblings (plants grown from seed that came from a single parent). Seedlings of Cakile edentula, a variety of wild mustard, grow much more dense and aggressive root structures when next to members of their own species that come from different parents. This is a remarkable level of sensitivity to a very slight variation in genetic structure -- but should come as no surprise to herbalists who are quite familiar with plants' ability to sense, perceive, process, and alter their behavior in concert with their environments.

6.12.2007

Trouble for antibiotics

Antibiotic resistance has been all over the news lately, with the media spotlight focused on the case of a man with extensively-drug-resistant tuberculosis who somehow eluded border checkpoints across Europe, Canada and the U.S.
We thought we had TB "licked", right? But the pesky little bug has somehow adapted to changing environmental conditions, and now modern medicine is left in a global panic when faced with the possible spread of a TB strain resistant to most available dugs. Treatment is expensive, long, and not always effective - and the specter of an even more powerful "superbug" looms large.

Hospitals, with their ubiquitous use of antibiotics, have long been havens for some ultra-potent, resistant strains of common bacteria like staph (Staphylococcus aureus). This bug can cause skin infections and systemic sepsis in the worst cases, but our immune systems usually take care of it pretty well (especially with a little Echinacea, an excellent remedy for this pathogen). In hospitals, a strain called MRSA (methycillin-resistant-staph-aureus) has been giving doctors headaches for a good while, ever since methycillin was extensively prescribed to kill bacteria that had become immune to penicillin. Now, they use vancomycin (ultra-strong antibiotic) to treat MRSA, but VRSA has already evolved and modern science has NO treatment available for this new bug. Things don't look too hopeful for the wonderdrugs that, in the 1950s, were heralded as the "end of infectious disease".

If this weren't enough, it turns out that MRSA has been spreading outside hospitals as well. A recent study showed a seven-fold increase in these cases over the period from 2000 to 2005, and this is just in the Chicago area. This is a concern because not only are these bacteria resistant to antibiotics, but they are generally more aggressive in the physiology as well, and can become lethal more quickly and easily than their original counterparts. Nevertheless, they still respond well to herbal treatment, especially if detected early.

In the wake of these types of reports (which have been ongoing), along with analyses that show how widely overused antibiotics are, modern medicine has been urging a less liberal prescription strategy so we can have these powerful drugs available when we really need them (i.e., not for your common cold)! And here's another reason: last month a broad analysis of over 13,000 children in Manitoba, Canada showed that antibiotic use in the first year of life substantially increases asthma later on, presumably by confusing and weakening the kids' immunity. The more frequent and more powerful the antibiotics, the greater the risk for asthma.

So, in the end, antibiotics seem to be less effective as time goes on, and actually quite harmful in some cases. More and more, it will be up to herbalists to pick up the pieces of our short and misguided love affair with these drugs. If you want to learn more, here's a good place to start.

6.11.2007

Vermont Center for Integrative Herbalism

We've started a new non-profit venture in Montpelier, focused on providing free herbal services (including access to a well-stocked apothecary) and a comprehensive herbalist training program. I've been personally involved in this work for over 7 years, and the momentum my friends and I have generated seems to be coalescing this Summer into what I hope will be a useful and powerful new resource for the Central Vermont community.
Read more from the Times Argus; or visit the website of the Vermont Center for Integrative Herbalism. And, if you're in Montpelier, Vermont this Friday evening, you can come visit at our benefit dinner and silent auction.

6.08.2007

Cannabinoids and skin allergies

Fresh research published in Science seems to hint at a topical anti-allergic effect for cannabinoids. The trial was done in mice using an artificial allergen, and the research proceeded in two steps: first, the scientists found that mice genetically engineered to lack cannabinoid receptors were much more sensitive to environmental allergens like nickel. I suspect the mice were modified as part of Dr. Karsak's ongoing obsession with understanding the role that mammalian cannabinoids (which occur naturally in our bodies, as well as in mice -- one example is anandamide) play in a variety of processes, from atherosclerosis, to generalized inflammation, to mood.
Anyway, Karsak and the rest of the research team decided to take things a step further, and see if cannabinoids from Cannabis itself could reduce skin sensitivity in normal mice. So they cooked up some kind of marijuana salve and applied it to mice that had been exposed to a synthetic allergen (2,4-dinitrofluorobenzene). The results: a 50% reduction in inflammation and swelling. While the mechanism of action is still unclear, preliminary evidence seems to point to cannabinoids' role in modulating the expression of genes that code for pro-inflammatory compounds like histamine. I'd be curious to hear more about this: it could help explain how effective marijuana has been in curbing GI and upper respiratory inflammation (colitis, asthma, e.g.) in previous studies, some of which were in humans.
One final note of wisdom from Roman Rukwied, a pain and inflammation researcher: "We are far before the day when we could say 'oh, I have a nickel allergy. I will smoke marijuana and I won't have it anymore'," he says. "That is definitely not the case." Fair enough.

6.04.2007

American Ginseng helps cancer-related fatigue

Panax quinquefolium, the gentler ginseng native to the Northeastern U.S., received an endorsement at this year's annual meeting of the American Society of Clinical Oncology. Debra Barton, of the Mayo Clinic, described how patients with fatigue and short (6 month) life expectancies were given P. quinquefolium for 8 weeks, at varying doses. The results seem to point to a marked improvement in vitality and a reduction of fatigue-like symptoms.

282 patients were given placebo, 750mg, 1000mg, or 2000mg of ginseng. The product was Wisconsin-grown American ginseng root, dried and encapsulated. All the patients in the active treatment groups reported improvement greater than placebo, with the higher doses showing greater positive response. Toxicity was absent in all treatment groups. The authors of the study seemed generally pleased with ginseng's effects and recommend additional research.

In my opinion, the doses used were still a little low. Traditionally, 3-4 grams a day are given, especially in conditions where the life force is severely challenged (as in this study's treatment group). Quality of life could be improved further not only by increasing the dose of ginseng, but also by selecting additional adaptogens and other herbs suited to the individualized constitutions of the people involved. Nevertheless, even in this one-size-fits-all approach, the life-enhancing power of this woodland plant still comes through. I am reminded of stories that talk about court physicians in China giving massive doses of prized ginseng roots to the Emperor during the last months/weeks of his life, to keep him active and alert in extremis so that the final affairs of the State could be settled.
One final note: beware, generally, of Wisconsin ginseng. It is often grown in massive industrial lots, covered with shade cloth, fed chemical fertilizers and liberally doused with fungicides. Insist on organically grown, preferably woods-grown organic, roots.